PORTLAND, Ore., Nov. 30, 2016 /PRNewswire/ -- Tricol Biomedical, Inc., a wholly owned subsidiary of Tricol International Group, Ltd., and a leading developer and marketer of the HemCon branded advanced wound care products, is inviting customers to explore its new website, available at www.tricolbiomedical.com.
The newly created Tricol website, designed with the latest technology, now has richer online content and provides an enhanced user experience. The improved site makes it easy to navigate through content and share information with others across all social media applications and offers a responsive layout on all platforms, including mobile devices.
The site design allows for streamlined menus and clear navigation that feature relevant content and product information to help better educate customers on the HemCon® line of products and solutions. The site is also designed to facilitate access to technical data, an education center, distribution options and enhance customer interactions.
"Since the acquisition of HemCon Medical Technologies, Inc. in April 2016, and the subsequent rebrand to Tricol Biomedical, Inc., the company has been able to fine-tune and focus its strategic direction to expand as a key player in the medical device industry," said Michael Wax, CEO of Tricol Biomedical.
"Rebranding has given the opportunity to highlight what sets this company apart from the competition, our comprehensive line of HemCon® brand of products," added Simona Buergi, VP of Sales & Marketing for Tricol Biomedical. "Our transformational strategy and innovative approach to presenting products and company information sends a clear message that we are dedicated to our future success and look forward to bringing our customers new and innovative product offerings to serve unmet needs in the market, and feature them on our new web platform."
About Tricol Biomedical, Inc.Tricol Biomedical Inc. (formerly HemCon Medical Technologies, Inc.), originally founded in 2001 and re-invented in April 2016, develops and markets innovative medical technologies that address wound care from closure to treatment. The company is the proud owner of the HemCon brand product line, designed for medical professionals in hospital, dental and clinical settings, as well as military and civilian first responders, where rapid control of bleeding is of critical importance. Tricol Biomedical is headquartered in Portland, Ore., with additional commercial operations in Ireland and the Czech Republic. For more information, please visit www.tricolbiomedical.com
About Tricol International Group, Ltd. Tricol International Group Ltd. is a Marshall Islands company and is substantially owned by Weifang Tricol Trading Co. Lid. headquartered in Weifang China. Tricol was created with the vision to provide customers and their families with the most innovative and high quality cleaning and home care products for both consumer and industrial use. Over the years, they have become the top supplier in the world for microfiber products, with capabilities of manufacturing chitosan microfibers and non-woven sheets and films. Tricol's mission is to continue to grow health product offerings and client bases to become the top supplier in the world for wound care solutions. For more information, please visit www.tricolgroup.com.
Media Contact:Simona Buergi135856@email4pr.com 503.245.0459
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tricol-biomedical-inc-announces-new-website-launch-and-corporate-rebrand-300370280.html
SOURCE Tricol Biomedical, Inc.
Subscribe to our Free Newsletters!
Fasciotomy is a surgical procedure where the fascia is incised to relieve the compartmental ...
Angioedema is a condition that causes leakage of blood vessels resulting in the swelling of deeper ...
Acute coronary syndrome (ACS) is a sudden, acute life-threatening condition caused by a dramatic ...View All